Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QPFZ | ISIN: US74039M3097 | Ticker-Symbol: S1K
NASDAQ
05.06.25 | 19:20
0,940 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREDICTIVE ONCOLOGY INC Chart 1 Jahr
5-Tage-Chart
PREDICTIVE ONCOLOGY INC 5-Tage-Chart

Aktuelle News zur PREDICTIVE ONCOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.05.Predictive Oncology to defend against Renovaro's claims in court6
27.05.Predictive Oncology Inc.: Court Denies Renovaro Motion for an Expedited Trial in July168PITTSBURGH, May 27, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding its dispute with Renovaro...
► Artikel lesen
22.05.Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology70LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today...
► Artikel lesen
22.05.Predictive Oncology nutzt KI für die Arzneimittelforschung2
22.05.Predictive Oncology harnesses AI for drug discovery3
22.05.Predictive Oncology Inc.: AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition394PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response...
► Artikel lesen
PREDICTIVE ONCOLOGY Aktie jetzt für 0€ handeln
20.05.Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"5
15.05.Predictive Oncology Inc. Q1 Loss Decreases5
15.05.Predictive Oncology Inc.: Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update75PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive...
► Artikel lesen
15.05.Predictive Oncology Inc. - 8-K, Current Report4
04.04.Renovaro says Predictive Oncology terminates merger transaction6
04.04.Renovaro Biosciences erlebt Rückschlag bei Fusion mit Predictive Oncology3
04.04.Renovaro Inc: Renovaro Provides Update to Definitive Agreement with Predictive Oncology355LOS ANGELES, April 04, 2025with Predictive Oncology Predictive Oncology, Inc.integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the...
► Artikel lesen
01.04.Predictive Oncology GAAP EPS of -$1.99, revenue of $1.62M4
01.04.Predictive Oncology Inc.: Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update154PITTSBURGH, April 01, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive...
► Artikel lesen
01.04.Predictive Oncology Inc. - 8-K, Current Report4
01.04.Predictive Oncology Inc. - S-8, Securities to be offered to employees in employee benefit plans5
31.03.Predictive Oncology Inc. - 10-K, Annual Report1
28.03.Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research7
25.03.What's Going On With Predictive Oncology Shares Tuesday?8
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1